Lam Research Corporation — Form 10-Q Summary
Reporting period: Fiscal third quarter and nine months ended March 25, 2012; each quarter comprised 13 weeks. The filing was signed May 3, 2012. Although the request metadata says “2011 Q3,” this filing reports fiscal 2012 Q3.
Business context and reporting period
Lam designs, manufactures, sells, and services semiconductor processing equipment, with a focus on etch and single-wafer clean systems. Results are cyclical and depend substantially on semiconductor manufacturers’ capital spending. Management said March-quarter shipments and revenue grew sequentially as leading-edge foundry customers increased capacity investment, particularly to serve mobile-related demand.
Financial results
| Metric | Three months ended Mar. 25, 2012 | Prior-year quarter | Nine months ended Mar. 25, 2012 | Prior-year period |
|---|---|---|---|---|
| Revenue | $659.0 million | $809.1 million | $1,923.4 million | $2,485.7 million |
| Gross margin | $267.1 million; 40.5% | $374.0 million; 46.2% | $785.9 million; 40.9% | $1,158.8 million; 46.6% |
| Operating income | $58.1 million | $197.0 million | $205.1 million | $662.1 million |
| Net income | $45.6 million | $182.2 million | $150.7 million | $597.8 million |
| Diluted EPS | $0.38 | $1.45 | $1.24 | $4.78 |
- Quarterly revenue rose 13% sequentially from $584.0 million, and net income rose from $33.2 million. Year over year, quarterly revenue declined about 19% and net income about 75%.
- For the nine-month period, revenue declined about 23% and net income about 75% year over year. Gross margin fell 5.7 percentage points for the quarter and 5.7 points year to date.
- March-quarter shipments were $713 million, up 27% sequentially and down 12% year over year. Systems at or below the 4x-nanometer technology node represented 91% of system shipments.
- Quarterly R&D was $113.4 million and SG&A was $95.6 million. Nine-month R&D and SG&A were $320.0 million and $259.0 million, respectively.
- The effective tax rate was 16.4% for the quarter and 17.1% year to date, compared with 8.3% and 9.9% in the respective prior-year periods. Management attributed the increase principally to earnings mix across jurisdictions and nondeductible stock compensation.
Cash flow, liquidity, and debt
- For the first nine months, operating cash flow was $402.3 million, versus $682.9 million a year earlier. Capital expenditures and intangible-asset spending were $70.4 million.
- Investing activities used $441.7 million, mainly reflecting net purchases of available-for-sale securities. Financing activities used $39.7 million, including $111.6 million of treasury-stock purchases.
- At March 25, cash and cash equivalents were $1.410 billion, short-term investments $993.7 million, and restricted cash and investments $165.2 million—approximately $2.569 billion combined. Management said liquidity was expected to support operations, investment, debt service, and capital expenditures for at least 12 months.
- Total assets were $4.193 billion and total liabilities $1.584 billion. The balance sheet reported $2.5 million of current debt, convertible notes, and capital leases, plus $755.4 million long term. The two convertible-note issues had $900 million aggregate face value: $450 million of 0.50% notes due 2016 and $450 million of 1.25% notes due 2018.
- Cash and investments increased from approximately $2.3 billion at fiscal year-end June 26, 2011. The company also had $115.6 million of uncertain-tax-benefit liabilities excluded from the contractual-obligations schedule because settlement timing and amount could not be reasonably estimated.
Material changes, outlook, and risks
- Sequential improvement reflected stronger leading-edge foundry investment and better factory utilization; lower utilization and customer/product mix contributed to weaker year-over-year gross margin. Management identified approximately $3 million of March-quarter gross-margin expense related to a customer bankruptcy filing.
- Operating expenses rose year over year, reflecting continued next-generation R&D, higher headcount and compensation, and costs associated with the proposed Novellus acquisition. Novellus integration planning was underway. The proposed all-stock acquisition was valued at approximately $3.3 billion when announced, subject to shareholder, regulatory, and other closing conditions.
- The board authorized up to $1.6 billion of share repurchases in connection with the Novellus transaction, replacing prior authorizations. During the March quarter, Lam repurchased 300,000 shares for $12.5 million under the program and received $79.2 million upon settlement of a structured repurchase arrangement.
- No specific next-quarter revenue or earnings guidance is provided in the supplied filing text. Management’s outlook is that existing cash and short-term investments should cover anticipated needs for at least 12 months; longer-term liquidity depends significantly on revenue and cost management.
- Key risks include semiconductor-industry cyclicality and volatile customer spending, concentration in a limited number of customers and products, system acceptance timing, technology and competitive pressures, reliance on key suppliers and outsource providers, international and foreign-exchange exposure, and execution or completion risks for the Novellus acquisition.
- Other notable matters include $1.7 million of investment impairment during the nine months, $27.955 million remaining under the 2009 restructuring plan for vacated facilities, and a $164.9 million restricted-cash balance supporting facility leases. The company reported ongoing intellectual-property claims but did not expect them to have a material adverse effect; tax audits were in progress, with no significant adjustments proposed by the IRS or California tax authority as of the filing.
Important facts for investors to verify
- Whether the sequential recovery in foundry demand continued and how customer, product, and regional mix affected revenue and margins.
- Whether gross margins recovered from approximately 40.5%, and whether R&D and acquisition-related spending translated into sustained growth and profitability.
- The status, final terms, financing and integration costs, and expected benefits of the Novellus transaction, as well as the effect of the associated repurchase authorization.
- Convertible-note obligations, potential dilution and hedge/warrant effects, and the company’s ability to sustain liquidity through a cyclical downturn.
- Developments in tax examinations and uncertain tax positions, customer credit exposures, and the facility residual-value guarantees.